Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors

This study has been terminated.
(Sponsor decision)
Sponsor:
Information provided by:
Exelixis
ClinicalTrials.gov Identifier:
NCT00796484
First received: November 20, 2008
Last updated: March 31, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: November 2010
  Estimated Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)